For the Inventor, By the Inventor

Enter assignee name

Leipzig, Germany

The Medicines Company (Leipzig) Gmbh

USPTO Granted Patents = 16

Forward Citations = 66

Loading Chart...

Loading Chart...

33 inventors (with patents filed for the assignee):

Andrea Schweinitz (13 out of 15 patents)

Torsten Steinmetzer (11 out of 17 patents)

Alexander Schulze (8 out of 8 patents)

4. Claudia Reichelt (8 out of 8 patents)

5. Friedrich-Alexander Ludwig (7 out of 7 patents)

6. Mohammed Daghish (7 out of 7 patents)

7. Jochen Heinicke (5 out of 5 patents)

8. Joerg Stuerzebecher (5 out of 7 patents)

9. Jörg Stürzebecher (4 out of 6 patents)

10. Stjepan Jelakovic (3 out of 13 patents)

11. Peter Herold (3 out of 54 patents)

12. Peter Steinmetzer (3 out of 3 patents)

13. Anett Soeffing (3 out of 3 patents)

14. Silke Nicklisch (3 out of 3 patents)

15. Andreas Van De Locht (3 out of 3 patents)

16 patents: Sort by Forward Citations

1. 9611290 - Trypsin-like serine protease inhibitors, and their preparation and use (2017-04-04),

2. 9365613 - Acylated 4-amidino- and -4-guanidinobenzylamines for inhibition of plasma kallikrein (2016-06-14),

3. 9090658 - Base-substituted benzylamine analogs for use as coagulation factor Xa inhibitors, the production and use thereof (2015-07-28),

4. 8921319 - Serine protease inhibitors (2014-12-30),

5. 8664233 - Substituted 5H-pyrimido[5,4-B]indoles, method for the production thereof and use thereof for treating non-solid malignant tumors of the blood-producing system (2014-03-04),

6. 8598206 - Trypsin-like serine protease inhibitors, and their preparation and use (2013-12-03),

7. 8569313 - Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors (2013-10-29),

8. 8513461 - Trypsin-like serine protease inhibitors, and their preparation and use (2013-08-20),

9. 8497245 - Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors IIa and Xa (2013-07-30),

10. 8476306 - Urokinase inhibitors, production and use thereof (2013-07-02),

11. 8410310 - Trypsin-like serine protease inhibitors, and their preparation and use (2013-04-02),

12. 8207378 - Trypsin-like serine protease inhibitors, and their preparation and use (2012-06-26),

13. 8124587 - 2-(aminomethyl)-5-chlorobenzylamide derivatives and their use as inhibitors of the clotting factor Xa (2012-02-28),

14. 8058285 - Substituted pyrido [3', 2′: 4, 5] thieno [3, 2-D] pyrimidines and pyrido [3′, 2′: 4, 5] furo [3, 2-D] pyrimidines used as inhibitors of the PDE-4 and/or the release of TNF-ALPHA (2011-11-15),

15. 7838560 - Urokinase inhibitors, production and use thereof (2010-11-23),

The Medicines Company (Leipzig) GmbH is a subsidiary of The Medicines Company, focusing on the development and commercialization of innovative pharmaceutical products. With a strong commitment to improving patient outcomes, the company is dedicated to finding solutions for unmet medical needs. Visit their website for more information on their products and initiatives.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#6 in Leipzig

#2,631 in Germany

#36,671 in the World

Leipzig, Germany

The Medicines Company (Leipzig) Gmbh

Forward Citations = 66

33 inventors:

Andrea Schweinitz (13 out of 15 patents)

Torsten Steinmetzer (11 out of 17 patents)

Alexander Schulze (8 out of 8 patents)

4. Claudia Reichelt (8 out of 8 patents)

5. Friedrich-Alexander Ludwig (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…